Le Lézard
Classified in: Business, Covid-19 virus
Subjects: FOR, CFG

/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Monday, March 16, 2020/


OTTAWA, March 15, 2020 /CNW/ -

Note: All times local

Ottawa, Ontario

Private meetings.

The Prime Minister will speak with G7 leaders.

 

1:00 p.m.    

The Prime Minister will address Canadians on the COVID-19 situation. The Deputy Prime Minister Chrystia Freeland, accompanied by Minister Patty Hajdu, Minister Jean-Yves Duclos, Minister Bill Blair, Minister Marc Garneau, and Chief Public Health Officer of Canada Dr. Theresa Tam, will then be available to answer additional questions at the National Press Theatre.




Rideau Cottage


1 Sussex Drive




Notes for media:




  • Open coverage
  • Media are asked to arrive to the Princess Anne Entrance no later than 12:15 p.m. and to make their way to the P1 Gate once on the grounds.
  • Media wishing to cover the event must be accredited with the Parliamentary Press Gallery.
  • Journalists who are not members of the Parliamentary Press Gallery should contact Pierre Cuguen at [email protected] to obtain temporary accreditation.

 

This document is also available at http://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 21:00
SETC-Assistance.org Helps Eligible Self-Employed Workers Receive Up to $32,220 in Tax Credits Through SETC Program
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

at 19:30
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

at 19:05
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:51
Bladex announces 1Q24 Net Profit of $51.3 Million, or $1.40 per share, expanding its annualized return on equity to 16.8% in 1Q24
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...

at 17:20
NOVAGOLD Releases 2023 Sustainability Report
Providing a comprehensive overview of NOVAGOLD's Environmental, Social and Governance (ESG) performance, emphasizing remarkable health and safety records, steadfast dedication to environmental protection, continuous community investment, extensive...

at 16:45
Dogness Reports Financial Results for the Six Months Ended December 31, 2023
Dogness (International) Corporation ("Dogness" or the "Company") , a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced its financial results for the six months ended December...

More news about Covid-19 virus...


News published on and distributed by: